Moloney M, Moriarty M, Daly L
Hum Nutr Appl Nutr. 1983 Feb;37(1):30-5.
Ninety-seven patients with cancer, undergoing radiation treatment, were studied. Forty-two were given special dietary counseling and supplements of Sustagen or Isocal; 42 controls received no special advice or supplements. Thirteen patients were excluded because of poor prognoses and the ethical need for food supplements. Nutrient intake of all groups was assessed by 3-d diet records in household measures in the first and the last week of treatment. Intake was significantly higher in the adjunctive than the control group. The excluded group, despite supplementation, had intakes similar to the control group. No difference was observed between the control and adjunctive groups in clinical status at the end of treatment or in long-term outcome.
对97名正在接受放射治疗的癌症患者进行了研究。42名患者接受了特殊的饮食咨询,并补充了苏士健(Sustagen)或艾素卡尔(Isocal);42名对照组患者未接受任何特殊建议或补充剂。由于预后不良以及食物补充剂的伦理需求,13名患者被排除在外。通过在治疗的第一周和最后一周以家庭量具记录的3天饮食情况来评估所有组的营养摄入量。辅助组的摄入量显著高于对照组。被排除的组尽管接受了补充剂,但摄入量与对照组相似。在治疗结束时的临床状况或长期结果方面,对照组和辅助组之间未观察到差异。